These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38206431)

  • 1. Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature.
    Lewis L; Thompson B; Stellmaker R; Koelmeyer L
    J Cancer Surviv; 2024 Jan; ():. PubMed ID: 38206431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer.
    Aleixo GFP; Shachar SS; Deal AM; Nyrop KA; Muss HB; Chen YT; Yu H; Williams GR
    Breast Cancer Res Treat; 2020 Aug; 182(3):631-642. PubMed ID: 32519169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?
    Drami I; Pring ET; Gould L; Malietzis G; Naghibi M; Athanasiou T; Glynne-Jones R; Jenkins JT
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e540-e552. PubMed ID: 34147322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review.
    Aleixo GFP; Williams GR; Nyrop KA; Muss HB; Shachar SS
    Breast Cancer Res Treat; 2019 Oct; 177(3):569-579. PubMed ID: 31292800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review.
    Rizzo S; Raia G; Del Grande M; Gasparri ML; Colombo I; Manganaro L; Papadia A; Del Grande F
    Front Oncol; 2022; 12():1057631. PubMed ID: 36408182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review.
    Wopat H; Harrod T; Brem RF; Kaltman R; Anderson K; Robien K
    J Cancer Surviv; 2023 Apr; ():. PubMed ID: 37093518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition change during neoadjuvant chemotherapy for breast cancer.
    Jang MK; Park S; Park C; Doorenbos AZ; Go J; Kim S
    Front Oncol; 2022; 12():941496. PubMed ID: 36091109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review.
    Rizzo S; Scala I; Robayo AR; Cefalì M; De Dosso S; Cappio S; Xhepa G; Del Grande F
    Front Oncol; 2022; 12():974116. PubMed ID: 36249069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer.
    Antoun S; Borget I; Lanoy E
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):383-9. PubMed ID: 24189893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.
    Sheean P; Gomez-Perez S; Joyce C; O'Connor P; Bojko M; Smith A; Vasilopoulos V; Rao R; Sclamberg J; Robinson P
    Breast Cancer Res Treat; 2021 Nov; 190(1):121-132. PubMed ID: 34389926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety in patients with breast cancer undergoing treatment: a systematic review.
    Ching LC; Devi MK; Kim Emily DNurs AN
    JBI Libr Syst Rev; 2010; 8(25):1016-1057. PubMed ID: 27820329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
    Cespedes Feliciano EM; Lee VS; Prado CM; Meyerhardt JA; Alexeeff S; Kroenke CH; Xiao J; Castillo AL; Caan BJ
    Cancer; 2017 Dec; 123(24):4868-4877. PubMed ID: 28881381
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.